Charts

News

05 Jan, 2023
Gainers Vyant Bio (NASDAQ:VYNT) stock moved upwards by 111.7% to $1.63 during Thursday's pre-market session. The company's market cap ...
28 Dec, 2022
Gainers Kala Pharmaceuticals (NASDAQ:KALA) shares moved upwards by 314.3% to $16.24 during Wednesday's regular session. Trading volume ...
Gainers Minerva Surgical (NASDAQ:UTRS) shares increased by 111.6% to $0.34 during Wednesday's pre-market session. The company's market ...
23 Dec, 2022
Gainers NexImmune (NASDAQ:NEXI) shares increased by 15.4% to $0.28 during Friday's after-market session. The market value of their ...
Gainers Immuron (NASDAQ:IMRN) shares increased by 37.9% to $2.22 during Friday's regular session. As of 12:30 EST, this security is ...
Gainers Immuron (NASDAQ:IMRN) stock increased by 42.2% to $2.29 during Friday's pre-market session. The company's market cap stands at ...
21 Dec, 2022
Gainers IsoPlexis (NASDAQ:ISO) shares moved upwards by 43.5% to $0.99 during Wednesday's after-market session. The market value of ...
Gainers ADC Therapeutics SA (NASDAQ: ADCT) shares rose 36.8% to $4.35 in pre-market trading. ADC Therapeutics and Sobi announced ...
20 Dec, 2022
Gainers IceCure Medical Ltd (NASDAQ: ICCM) shares jumped 296% to $3.71 after the company announced interim results from the ...
Wall Street closed lower for the fourth straight session on Monday. Investors, meanwhile, focused on some notable insider ...
Gainers Exicure (NASDAQ:XCUR) shares moved upwards by 73.2% to $1.23 during Tuesday's pre-market session. The company's market cap ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Tuesday morning! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tueday appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air” It doesn’t matter if you have $500 or $5 million. Do this now.
Gainers IceCure Medical Ltd (NASDAQ: ICCM) shares rose 158% to $2.42 in pre-market trading after the company announced interim ...
14 Dec, 2022
Exicure, Inc. Announces Termination of AbbVie and Ipsen Collaboration Agreements
15 Nov, 2022
In its Q3 earnings release,Exicure Inc's(NASDAQ:XCUR) managementwarned of substantial ...
14 Nov, 2022
Exicure reported financial results for the quarter ended September 30, 2022 and provided an update on its business strategy and corporate progress.
02 Nov, 2022
Gainers Avinger, Inc. (NASDAQ: AVGR) rose 32% to $1.36 in pre-market trading. Avinger is expected to release its financial results ...
28 Sep, 2022
Gainers Avenue Therapeutics, Inc. (NASDAQ: ATXI) shares climbed 106.3% to close at $9.15. Avenue Therapeutics recently received ...
27 Sep, 2022
U.S. stocks traded lower, with the Dow Jones dropping around 180 points on Tuesday. Here are some big stocks recording losses in ...
Exicure Inc(NASDAQ: XCUR) announcedrestructuring plansand aligned resources to continue exploring strategic ...
Pre-open movers U.S. stock futures traded higher in early pre-market trade on Tuesday after recording losses on Monday. The Dow Jones ...
With US stock futures trading higher this morning on Tuesday, some of the stocks that may grab investor focus today are as ...
26 Sep, 2022
Exicure announced plans to restructure the Company and align resources to continue exploring strategic alternatives that maximize stockholder value.
CHICAGO, September 26, 2022--Exicure announced plans to restructure the Company and align resources to continue exploring strategic alternatives that maximize stockholder value.
01 Sep, 2022
Exicure CEO Matthias Schroff will provide a live presentation at the 2022 Chardan Genetic Medicines Conference.
30 Aug, 2022
Gainers Mobile Global Esports Inc. (NASDAQ: MGAM) shares rose 28.1% to $3.33 in pre-market trading after gaining over 5% on ...
17 Aug, 2022
15 Aug, 2022
Exicure today reported financial results for the quarter ended June 30, 2022 and provided an update on its business strategy and corporate progress.
Gainers Plus Therapeutics, Inc. (NASDAQ: PSTV) shares rose 31.2% to $0.6931 in pre-market trading as the company presented ...
05 Aug, 2022
Gainers ChemoCentryx, Inc. (NASDAQ: CCXI) surged 109.2% to settle at $50.43 on Thursday after the company, and Amgen, announced ...
04 Aug, 2022
Gainers InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) shares jumped 178.5% to $12.45 after gaining over 12% on ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning! It's time for another dive into the biggest pre-market stock movers as we see what's affecting shares on Thursday! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air” Cash Holders Could Get Hit Hard THIS FRIDAY
Gainers Missfresh Limited (NASDAQ: MF) shares rose 112.9% to $0.2450 in pre-market trading after dropping 7% on ...
Gainers Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) shares surged 360.5% to settle at $19.80 on Wednesday on above-average ...
20 Jul, 2022
Exicure, Inc. (Nasdaq: XCUR), an early-stage biotechnology company focused on the development of next generation nucleic acid therapies targeting RNA to address both genetic and non-genetic neurological disorders and hair loss disorders, today announced that on July 19, 2022, it received a letter from the Office of General Counsel of The Nasdaq Stock Market LLC informing it that Nasdaq has confirmed that the Company has regained compliance with the $1.00 per share minimum bid price requirement pursuant to Nasdaq Listing Rule 5450(a)(1) and that the Company is in compliance with all applicable listing standards. Accordingly, the scheduled hearing before the Nasdaq Hearings Panel has been cancelled and the Company’s Common Stock will continue to be listed and traded on The Nasdaq Capital Market.
11 Jul, 2022
Gainers Novo Integrated Sciences (NASDAQ:NVOS) shares increased by 21.7% to $2.3 during Monday's after-market session. The market ...
07 Jul, 2022
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) rose 39.6% to $0.2471 in pre-market trading after declining over 8% on ...
01 Jul, 2022
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, trader! It's time for another look at the biggest pre-market stock movers as we dive into the latest news for Friday! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday appeared first on InvestorPlace. More From InvestorPlace $200 Oil Sooner Than You Think – Buy This Now The Best $1 Investment You Can Make Today Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air” It doesn’t matter if you have $500 in savings or $5 million. Do this now.
Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) surged 77.4% to close at $1.11 on Thursday after jumping 27% on Wednesday. ...
30 Jun, 2022
Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) jumped 171.3% to $1.70 after jumping 27% on Wednesday. Revelation ...
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus US Government Calls For ...
29 Jun, 2022
CHICAGO, June 29, 2022--Exicure, Inc. (NASDAQ: XCUR), an early-stage biotechnology company focused on the development of next generation nucleic acid therapies targeting RNA to address both genetic and non-genetic neurological disorders and hair loss disorders, today announced that, following the implementation of a one-for-thirty reverse stock split at 5:00 p.m. EDT today, the Company’s common stock will begin trading on a split-adjusted basis on Nasdaq effective with the open of business tomor
27 May, 2022
CHICAGO, May 27, 2022--Exicure, Inc. (NASDAQ: XCUR), an early-stage biotechnology company focused on the development of next generation nucleic acid therapies targeting RNA to address both genetic and non-genetic neurological disorders and hair loss disorders, today announced that the Company’s Annual Meeting of Stockholders (the "Annual Meeting") held in virtual format on Friday, May 27, 2022 at 1:00 p.m. Central Time, was convened and adjourned until June 10, 2022 at 1:00 p.m. Central Time wit
20 May, 2022
17 May, 2022
CHICAGO, May 17, 2022--Exicure today announced that CEO Matthias Schroff will provide a virtual presentation at the 2022 H.C. Wainwright Global Life Sciences Conference.
16 May, 2022
CHICAGO, May 16, 2022--Exicure today reported financial results for the quarter ended March 31, 2022 and provided an update on its business strategy and corporate progress.
10 May, 2022
CHICAGO, May 10, 2022--Exicure, Inc.® (NASDAQ:XCUR), an early-stage biotechnology company focused on the development of next generation nucleic acid therapies targeting RNA to address both genetic and non-genetic neurological disorders and hair loss disorders, today announced that it has agreed to sell an aggregate of 26,021,111 shares of its common stock at a purchase price of $0.1937 per share to certain accredited investors in a private placement in public equity ("PIPE") financing. The purch
09 May, 2022
CHICAGO, May 09, 2022--Exicure, Inc. today announced a poster presentation at TIDES USA 2022, May 9-12, 2022.
25 Mar, 2022
20:26
Seeking Alpha
CHICAGO, March 25, 2022--Exicure, Inc. (NASDAQ: XCUR), a pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA™) technology, today reported full year financial results for the quarter and year ended December 31, 2021 and provided an update on its business strategy and corporate progress.
04 Feb, 2022
CHICAGO, February 04, 2022--Exicure, Inc. Announces Leadership Transition and Changes to the Board of Directors
19 Nov, 2021
10 Sep, 2021
19:55
Seeking Alpha
12 Aug, 2021
23 Mar, 2021
31 Dec, 2020
18:30
Seeking Alpha
12 Nov, 2020
01 Oct, 2020

Related Articles